首页> 外国专利> Use of 4 (6) trifluormetilpirimidin - 2 (1H) - onas n - replaced in the treatment of Alzheimer's disease and other diseases characterized by the decrease in the production or action of the neurotransmitter acetylcholine.

Use of 4 (6) trifluormetilpirimidin - 2 (1H) - onas n - replaced in the treatment of Alzheimer's disease and other diseases characterized by the decrease in the production or action of the neurotransmitter acetylcholine.

机译:使用4(6)三氟甲嘧啶-2(1H)-n-取代n-用于治疗阿尔茨海默氏病和其他以神经递质乙酰胆碱的产生或作用降低为特征的其他疾病。

摘要

The present invention describes a method of treatment of Alzheimer's and other diseases that are caused by the decrease of the production or action of acetylcholine. Specifically, the present invention includes the use of 4 (6) trifluormetilpirimidin - 2 (1H) - onas n - replaced as which inhibit the enzyme acetylcholinesterase, thereby preventing the degradation of the neurotransmitter acetylcholine, increasing its concentration.The present invention is situated in the fields of pharmacology and medicine.
机译:本发明描述了一种治疗由乙酰胆碱的产生或作用降低引起的阿尔茨海默氏病和其他疾病的方法。具体地,本发明包括使用4(6)-三氟甲吡嘧啶-2(1H)-n-取代,其抑制乙酰胆碱酯酶,从而防止神经递质乙酰胆碱降解,增加其浓度。药理学和医学领域。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号